Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
To cover taxesNo plan disclosedOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 3 of the 13 calendar months from Oct 2025 to Oct 2026: Apr 2026, Jun 2026 and Jul 2026.
- Largest single sale: $763K (25,760 shares) of Immunovant, Inc. on Apr 23, 2026. Filing
- No sale on record before this period.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Immunovant, Inc. (IMVT) | Chief Financial Officer | May 5, 2025 | Jul 24, 2026 |
Recent filings
The last 4 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Jul 23, 2026, Immunovant, Inc.: sold 6,798 shares for $263K, to cover taxes. 1 filing: 1
- Jun 26, 2026, Immunovant, Inc.: sold 10,000 shares for $385K, no plan disclosed; 10,000 shares acquired by exercising options. 1 filing: 1
- Apr 23, 2026, Immunovant, Inc.: sold 25,760 shares for $763K, to cover taxes. 1 filing: 1
- Apr 7, 2026, Immunovant, Inc.: 64,968 shares granted. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.